中文名：鹽酸表柔比星
英文名：Epirubicin (IMI 28) HCl
英文別名：NSC?256942, 4'-epidoxorubicin HCl;(8S,?10S)?-10-?[(3-?amino-?2,?3,?6-?trideoxy-?α-?L-?arabino-?hexopyranosyl)?oxy]?-?7,?8,?9,?10-?tetrahydro-?6,?8,?11-?trihydroxy-?8-?(2-?hydroxyacetyl)?-?1-?methoxy-5,?12-?naphthacenedione, hydrochloride (1:1)
純度：10mM in DMSO
貨號(hào)：E408486
包裝：1ml
Cas號(hào)：56390-09-1
存儲(chǔ)溫度：-80℃儲(chǔ)存
產(chǎn)品介紹：
Information
Epirubicin (IMI 28) HCl Epirubicin HCl (IMI 28, NSC?256942, 4'-epidoxorubicin), a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase. Epirubicin induces apoptosis.
In?vitro
Epirubicin, like doxorubicin, exerts its antitumor effects by complex with DNA, resulting in damage to DNA and interference with the synthesis of DNA, RNA, and proteins. Epirubicin may also affect the integrity and activity of cellular membranes. Maximal cell kill caused by Epirubicin occurs during the S phase of the cell cycle. With higher concentrations effects are also seen in early G2 as well as G1 and M phases. Epirubicin display antineoplastic activity against most cancer cells. Epirubicin is cytotoxic to Hepatoma G2 cells with IC50 of 1.6 μg/mL at 24hr. 1.6 μg/mL Epirubicin induces apoptosis of Hep G2 cells, and higher activity of catalase by 50%, Se-dependent glutathione peroxidase by 110%, Cu, Zn-superoxide dismutase by 172% and Mn-superoxide dismutase by 135%. Epirbicin increases the cellular expression of NADPH-CYP 450 reductase, and reduces GST-π expression.
In?vivo
Epirubicin are clinically active against a broad range of tumor types, including breast cancer, malignant lymphomas, soft tissue sarcomas, lung cancer, pleural mesothelioma, gastrointestinal cancer, head and neck cancer, ovarian cancer, prostatic carcinoma, transitional bladder carcinoma and so on. Epirubicin at a dose of 3.5 mg/kg suppresses tumor mass of human breast tumor xenograft R-27 by 74.4 %.
Cell?Data
cell?lines：
Concentrations：0.05-12 μg/mL
Incubation?Time：1 days
Powder?Purity:≥97%
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對(duì)應(yīng)頁面：https://www.aladdin-e.com/zh_cn/E408486.html
關(guān)鍵字： NSC?256942, 4'-epidoxorubicin HCl;(8S,?10S)?-10-?[(3-?amino-?2,?3,?6-?trideoxy-?α-?L-?arabino-?hexopyranosyl)?oxy]?-?7,?8,?9,?10-?tetrahydro-?6,?8,?11-?trihydroxy-?8-?(2-?hydroxyacetyl)?-?1-?methoxy-5,?12-?naphthacenedione, hydrochloride (1:1)
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產(chǎn)和銷售，已陸續(xù)建立多個(gè)工廠和研發(fā)中心。作為領(lǐng)軍企業(yè)，阿拉丁始終堅(jiān)持質(zhì)量第一，連續(xù)13年被評(píng)為“最受歡迎試劑品牌”。
阿拉丁目前常備庫存試劑產(chǎn)品品種超過7萬種，SKU總數(shù)超過46萬，產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個(gè)領(lǐng)域，是國內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國產(chǎn)試劑品牌，產(chǎn)品同步發(fā)布在我們國內(nèi)外電商平臺(tái)。